PTPN1 and type 2 diabetes mellitus: Novel molecular targets are also investigated like aldose reductase (AR) and protein tyrosine phosphatase 1B (PTP1B), two key enzymes involved in different events which are critical for the onset and progression of T2DM and related comorbidities.